Mestag Therapeutics is based in Cambridge, UK. It has raised $95M in total funding. Latest round: Seed.
Mestag Therapeutics funding overview
Mestag Therapeutics is based in Cambridge, UK. Mestag Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in March 2026. The round record for Mestag Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include SV Health Investors, Johnson & Johnson Innovation – JJDC, Inc., Forbion, GV, Northpond Ventures. 5 distinct backers are named across the disclosed rounds.
Mestag Therapeutics at a glance
Total raised
$95M
Latest round
Seed
Latest round date
March 2026
Headquarters
Cambridge, UK
Notable investors
SV Health Investors, Johnson & Johnson Innovation – JJDC, Inc., Forbion, GV, Northpond Ventures
Frequently asked about Mestag Therapeutics funding
How much has Mestag Therapeutics raised?
Mestag Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Mestag Therapeutics?
SV Health Investors, Johnson & Johnson Innovation – JJDC, Inc., Forbion, GV, Northpond Ventures are named among the investors backing Mestag Therapeutics.
What was the latest Mestag Therapeutics funding round?
The most recent disclosed round is a Seed, announced in March 2026.
Where is Mestag Therapeutics based?
Mestag Therapeutics is based in Cambridge, UK.
When did Mestag Therapeutics last raise?
The last disclosed Mestag Therapeutics round closed in March 2026 at Seed.
Round data for Mestag Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
